Quantum Biopharma (QNTM) Competitors $12.30 +0.91 (+7.99%) Closing price 04:00 PM EasternExtended Trading$12.25 -0.05 (-0.41%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock QNTM vs. ENTX, KYTX, OPTN, HLVX, IMUX, CRDL, ZNTL, VXRT, ORMP, and PLRXShould you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Entera Bio (ENTX), Kyverna Therapeutics (KYTX), OptiNose (OPTN), HilleVax (HLVX), Immunic (IMUX), Cardiol Therapeutics (CRDL), Zentalis Pharmaceuticals (ZNTL), Vaxart (VXRT), Oramed Pharmaceuticals (ORMP), and Pliant Therapeutics (PLRX). These companies are all part of the "pharmaceutical products" industry. Quantum Biopharma vs. Entera Bio Kyverna Therapeutics OptiNose HilleVax Immunic Cardiol Therapeutics Zentalis Pharmaceuticals Vaxart Oramed Pharmaceuticals Pliant Therapeutics Entera Bio (NASDAQ:ENTX) and Quantum Biopharma (NASDAQ:QNTM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk, institutional ownership and community ranking. Which has more volatility and risk, ENTX or QNTM? Entera Bio has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, Quantum Biopharma has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Does the media prefer ENTX or QNTM? In the previous week, Quantum Biopharma had 3 more articles in the media than Entera Bio. MarketBeat recorded 4 mentions for Quantum Biopharma and 1 mentions for Entera Bio. Entera Bio's average media sentiment score of 0.83 beat Quantum Biopharma's score of -0.75 indicating that Entera Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Entera Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has higher earnings & valuation, ENTX or QNTM? Entera Bio has higher revenue and earnings than Quantum Biopharma. Entera Bio is trading at a lower price-to-earnings ratio than Quantum Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEntera Bio$223K389.30-$8.89M-$0.26-7.35Quantum BiopharmaN/AN/A-$17.90M-$15.98-0.77 Do analysts rate ENTX or QNTM? Entera Bio presently has a consensus target price of $10.00, suggesting a potential upside of 423.56%. Given Entera Bio's stronger consensus rating and higher possible upside, analysts clearly believe Entera Bio is more favorable than Quantum Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Entera Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Quantum Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ENTX or QNTM more profitable? Quantum Biopharma's return on equity of -84.21% beat Entera Bio's return on equity.Company Net Margins Return on Equity Return on Assets Entera BioN/A -107.24% -92.29% Quantum Biopharma N/A -84.21%-62.63% Does the MarketBeat Community believe in ENTX or QNTM? Entera Bio received 180 more outperform votes than Quantum Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformEntera BioOutperform Votes18067.67% Underperform Votes8632.33% Quantum BiopharmaN/AN/A Do institutionals and insiders hold more shares of ENTX or QNTM? 14.1% of Entera Bio shares are owned by institutional investors. Comparatively, 1.2% of Quantum Biopharma shares are owned by institutional investors. 10.9% of Entera Bio shares are owned by company insiders. Comparatively, 8.5% of Quantum Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryEntera Bio beats Quantum Biopharma on 11 of the 15 factors compared between the two stocks. Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNTM vs. The Competition Export to ExcelMetricQuantum BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.28M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-0.808.9226.8419.71Price / SalesN/A250.95391.39116.98Price / CashN/A65.8538.2534.62Price / Book0.586.466.794.50Net Income-$17.90M$143.98M$3.23B$248.18M7 Day Performance49.64%3.04%4.07%1.14%1 Month Performance97.12%7.44%12.52%15.20%1 Year PerformanceN/A-2.46%16.83%6.56% Quantum Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNTMQuantum BiopharmaN/A$12.30+8.0%N/AN/A$33.28MN/A-0.80N/ANews CoverageEarnings ReportENTXEntera Bio1.8091 of 5 stars$2.15flat$10.00+365.1%-10.4%$97.66M$223,000.00-8.2720News CoveragePositive NewsGap UpKYTXKyverna Therapeutics2.3955 of 5 stars$2.21+4.7%$18.33+729.6%-83.4%$95.51M$7.03M-0.6496News CoverageAnalyst RevisionGap UpOPTNOptiNose2.997 of 5 stars$9.42+0.3%$9.00-4.5%-46.7%$95.09M$78.23M-2.24190News CoverageAnalyst ForecastAnalyst RevisionHLVXHilleVax2.5015 of 5 stars$1.89-0.5%$3.00+58.7%-86.1%$94.77MN/A-0.6120News CoveragePositive NewsIMUXImmunic2.4106 of 5 stars$0.99-2.3%$13.20+1,237.8%-24.5%$94.54MN/A-0.8070Earnings ReportGap DownCRDLCardiol Therapeutics1.6121 of 5 stars$1.13-1.7%$8.40+643.4%-48.6%$93.35MN/A-2.9020Negative NewsZNTLZentalis Pharmaceuticals2.085 of 5 stars$1.29+4.9%$8.24+539.1%-89.1%$92.82M$67.43M-0.52160News CoverageEarnings ReportAnalyst RevisionVXRTVaxart2.3856 of 5 stars$0.41-3.5%$3.00+640.7%-43.3%$92.42M$28.70M-0.99120News CoverageORMPOramed Pharmaceuticals1.7805 of 5 stars$2.24-0.4%N/A-9.3%$91.50M$1.34M20.3610Earnings ReportPLRXPliant Therapeutics4.2448 of 5 stars$1.47+4.3%$13.31+805.6%-90.9%$90.24M$1.58M-0.4490Positive News Related Companies and Tools Related Companies Entera Bio Alternatives Kyverna Therapeutics Alternatives OptiNose Alternatives HilleVax Alternatives Immunic Alternatives Cardiol Therapeutics Alternatives Zentalis Pharmaceuticals Alternatives Vaxart Alternatives Oramed Pharmaceuticals Alternatives Pliant Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNTM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QNTM Stock Free QNTM Stock Alerts